$CLVS Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Clovis Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Clovis Oncology, Inc.. Get notifications about new insider transactions in Clovis Oncology, Inc. for free.
Page: < prev 1 ... 2 3 4 5 6 7 8 9 ... 9 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 5,625 | |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Sell | S | 21.23 | 284 | 6,029 | 14,162 | 14.4 K to 14.2 K (-1.97 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 625 | 0 | 14,446 | 13.8 K to 14.4 K (+4.52 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 5,625 | |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 5,625 | |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 21.23 | 250 | 5,308 | 186,152 | 186.4 K to 186.2 K (-0.13 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 21.23 | 250 | 5,308 | 186,152 | 186.4 K to 186.2 K (-0.13 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 186,402 | 185.8 K to 186.4 K (+0.34 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 186,402 | 185.8 K to 186.4 K (+0.34 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 469 | 0 | 4,219 | |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 469 | 0 | 4,219 | |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 21.23 | 188 | 3,991 | 5,664 | 5.9 K to 5.7 K (-3.21 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Sell | S | 21.23 | 188 | 3,991 | 5,664 | 5.9 K to 5.7 K (-3.21 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 469 | 0 | 5,852 | 5.4 K to 5.9 K (+8.71 %) |
| Dec 06 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 469 | 0 | 5,852 | 5.4 K to 5.9 K (+8.71 %) |
| Nov 28 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 546 | 0 | 3,828 | |
| Nov 28 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Payment of Exercise | F | 16.62 | 237 | 3,939 | 5,383 | 5.6 K to 5.4 K (-4.22 %) |
| Nov 28 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 546 | 0 | 5,620 | 5.1 K to 5.6 K (+10.76 %) |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | Flaherty Keith T. | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | Flaherty Keith T. | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | GRAHAM GINGER L | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | GRAHAM GINGER L | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | Azelby Robert | Director | Option Exercise | A | 27.92 | 25,848 | 721,676 | 25,848 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | Azelby Robert | Director | Option Exercise | A | 27.92 | 25,848 | 721,676 | 25,848 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | McKinley Edward J | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | McKinley Edward J | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | Fair Richard A. | Director | Option Exercise | A | 27.92 | 25,848 | 721,676 | 25,848 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | Fair Richard A. | Director | Option Exercise | A | 27.92 | 25,848 | 721,676 | 25,848 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | BARRETT M JAMES | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Oct 15 2018 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Option Exercise | A | 27.92 | 14,770 | 412,378 | 14,770 | |
| Sep 24 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 3,437 | 0 | 30,938 | |
| Sep 24 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Payment of Exercise | F | 32.21 | 1,728 | 55,659 | 13,821 | 15.5 K to 13.8 K (-11.11 %) |
| Sep 24 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 3,437 | 0 | 15,549 | 12.1 K to 15.5 K (+28.38 %) |
| Sep 24 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 16,875 | |
| Sep 24 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 32.21 | 829 | 26,702 | 185,777 | 186.6 K to 185.8 K (-0.44 %) |
| Sep 24 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 186,606 | 184.7 K to 186.6 K (+1.01 %) |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 469 | 0 | 4,688 | |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Payment of Exercise | F | 35.75 | 212 | 7,579 | 5,074 | 5.3 K to 5.1 K (-4.01 %) |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 469 | 0 | 5,286 | 4.8 K to 5.3 K (+9.74 %) |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 6,250 | |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Payment of Exercise | F | 35.75 | 321 | 11,476 | 12,112 | 12.4 K to 12.1 K (-2.58 %) |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 625 | 0 | 12,433 | 11.8 K to 12.4 K (+5.29 %) |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 6,250 | |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 35.75 | 282 | 10,082 | 184,731 | 185 K to 184.7 K (-0.15 %) |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 185,013 | 184.4 K to 185 K (+0.34 %) |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | M | 0.00 | 469 | 0 | 4,688 | |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Payment of Exercise | F | 35.75 | 239 | 8,544 | 5,349 | 5.6 K to 5.3 K (-4.28 %) |
| Sep 07 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Buy | M | 0.00 | 469 | 0 | 5,588 | 5.1 K to 5.6 K (+9.16 %) |
| Aug 28 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 547 | 0 | 4,374 | |
| Aug 28 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Payment of Exercise | F | 35.15 | 242 | 8,506 | 4,817 | 5.1 K to 4.8 K (-4.78 %) |
| Aug 28 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 547 | 0 | 5,059 | 4.5 K to 5.1 K (+12.12 %) |
| Aug 28 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | M | 0.00 | 869 | 0 | 6,950 | |
| Aug 28 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Payment of Exercise | F | 35.15 | 434 | 15,255 | 5,119 | 5.6 K to 5.1 K (-7.82 %) |
| Aug 28 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Buy | M | 0.00 | 869 | 0 | 5,553 | 4.7 K to 5.6 K (+18.55 %) |
| Jun 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 18,750 | |
| Jun 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 45.75 | 829 | 37,927 | 184,388 | 185.2 K to 184.4 K (-0.45 %) |
| Jun 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 185,217 | 183.3 K to 185.2 K (+1.02 %) |
| Jun 21 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 3,438 | 0 | 34,375 | |
| Jun 21 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Payment of Exercise | F | 45.75 | 1,728 | 79,056 | 11,808 | 13.5 K to 11.8 K (-12.77 %) |
| Jun 21 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 3,438 | 0 | 13,536 | 10.1 K to 13.5 K (+34.05 %) |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | M | 0.00 | 468 | 0 | 5,157 | |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Payment of Exercise | F | 47.70 | 235 | 11,210 | 4,684 | 4.9 K to 4.7 K (-4.78 %) |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Buy | M | 0.00 | 468 | 0 | 4,919 | 4.5 K to 4.9 K (+10.51 %) |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 6,875 | |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 47.70 | 278 | 13,261 | 183,342 | 183.6 K to 183.3 K (-0.15 %) |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 625 | 0 | 183,620 | 183 K to 183.6 K (+0.34 %) |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 468 | 0 | 5,157 | |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Payment of Exercise | F | 47.70 | 208 | 9,922 | 4,512 | 4.7 K to 4.5 K (-4.41 %) |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 468 | 0 | 4,720 | 4.3 K to 4.7 K (+11.01 %) |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 625 | 0 | 6,875 | |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Payment of Exercise | F | 47.70 | 316 | 15,073 | 10,098 | 10.4 K to 10.1 K (-3.03 %) |
| Jun 08 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 625 | 0 | 10,414 | 9.8 K to 10.4 K (+6.38 %) |
| Jun 01 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 547 | 0 | 4,921 | |
| Jun 01 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Payment of Exercise | F | 48.63 | 248 | 12,060 | 4,252 | 4.5 K to 4.3 K (-5.51 %) |
| Jun 01 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 547 | 0 | 4,500 | 4 K to 4.5 K (+13.84 %) |
| Jun 01 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | M | 0.00 | 869 | 0 | 7,819 | |
| Jun 01 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Payment of Exercise | F | 48.63 | 444 | 21,592 | 4,451 | 4.9 K to 4.5 K (-9.07 %) |
| Jun 01 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Buy | M | 0.00 | 869 | 0 | 3,958 | 3.1 K to 4 K (+28.13 %) |
| May 23 2018 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 5,897 | 0 | 12,917 | 7 K to 12.9 K (+84.00 %) |
| May 23 2018 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 32,760 | 0 | 0 | 32.8 K to 0 (-100.00 %) |
| Apr 09 2018 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Sell | S | 60.02 | 4,500 | 270,090 | 7,618 | 12.1 K to 7.6 K (-37.13 %) |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 3,437 | 0 | 37,813 | |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Payment of Exercise | F | 56.75 | 1,728 | 98,064 | 9,789 | 11.5 K to 9.8 K (-15.00 %) |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 3,437 | 0 | 11,517 | 8.1 K to 11.5 K (+42.54 %) |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 20,625 | |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 56.75 | 829 | 47,046 | 182,995 | 183.8 K to 183 K (-0.45 %) |
| Mar 21 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 183,824 | 181.9 K to 183.8 K (+1.03 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Sell | S | 61.47 | 4,500 | 276,615 | 12,118 | 16.6 K to 12.1 K (-27.08 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 5,625 | |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Payment of Exercise | F | 58.43 | 826 | 48,263 | 3,953 | 4.8 K to 4 K (-17.28 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 4,779 | 2.9 K to 4.8 K (+64.57 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | M | 0.00 | 1,875 | 0 | 5,625 | |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Payment of Exercise | F | 58.43 | 938 | 54,807 | 4,026 | 5 K to 4 K (-18.90 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Buy | M | 0.00 | 1,875 | 0 | 4,964 | 3.1 K to 5 K (+60.70 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 2,500 | 0 | 7,500 | |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Payment of Exercise | F | 58.43 | 1,260 | 73,622 | 8,080 | 9.3 K to 8.1 K (-13.49 %) |
| Mar 09 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 2,500 | 0 | 9,340 | 6.8 K to 9.3 K (+36.55 %) |
| Mar 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 2,500 | 0 | 7,500 | |
| Mar 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 58.43 | 1,122 | 65,558 | 181,949 | 183.1 K to 181.9 K (-0.61 %) |
| Mar 07 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 2,500 | 0 | 183,071 | 180.6 K to 183.1 K (+1.38 %) |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | A | 58.43 | 9,000 | 525,870 | 9,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | A | 58.43 | 9,000 | 525,870 | 9,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | A | 58.43 | 11,000 | 642,730 | 11,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | MAHAFFY PATRICK J | See Remarks | Option Exercise | A | 58.43 | 120,000 | 7,011,600 | 120,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | A | 0.00 | 11,000 | 0 | 11,000 | |
| Mar 02 2018 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | A | 58.43 | 11,000 | 642,730 | 11,000 | |
| Feb 23 2018 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Sell | S | 60.00 | 4,500 | 270,000 | 16,618 | 21.1 K to 16.6 K (-21.31 %) |
| Feb 16 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 54.09 | 3,000 | 162,270 | 180,571 | 183.6 K to 180.6 K (-1.63 %) |
| Jan 17 2018 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 59.16 | 3,000 | 177,480 | 183,571 | 186.6 K to 183.6 K (-1.61 %) |
| Jan 09 2018 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Sell | S | 64.97 | 4,500 | 292,365 | 21,118 | 25.6 K to 21.1 K (-17.57 %) |
| Dec 21 2017 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Option Exercise | M | 0.00 | 13,750 | 0 | 41,250 | |
| Dec 21 2017 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Payment of Exercise | F | 63.80 | 6,910 | 440,858 | 6,840 | 13.8 K to 6.8 K (-50.25 %) |
| Dec 21 2017 | CLVS | Clovis Oncology, I ... | Rolfe Lindsey | See Remarks | Buy | M | 0.00 | 13,750 | 0 | 13,750 | 0 to 13.8 K |
| Dec 21 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Option Exercise | M | 0.00 | 7,500 | 0 | 22,500 | |
| Dec 21 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Payment of Exercise | F | 63.80 | 3,512 | 224,066 | 186,571 | 190.1 K to 186.6 K (-1.85 %) |
| Dec 21 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Buy | M | 0.00 | 7,500 | 0 | 190,083 | 182.6 K to 190.1 K (+4.11 %) |
| Dec 18 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 64.16 | 3,000 | 192,480 | 182,583 | 185.6 K to 182.6 K (-1.62 %) |
| Dec 08 2017 | CLVS | Clovis Oncology, I ... | SPICKSCHEN THORLEF | Director | Sell | S | 60.00 | 4,500 | 270,000 | 25,618 | 30.1 K to 25.6 K (-14.94 %) |
| Dec 01 2017 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 547 | 0 | 6,015 | |
| Dec 01 2017 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Payment of Exercise | F | 59.49 | 259 | 15,408 | 2,616 | 2.9 K to 2.6 K (-9.01 %) |
| Dec 01 2017 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 547 | 0 | 2,875 | 2.3 K to 2.9 K (+23.50 %) |
| Dec 01 2017 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | M | 0.00 | 868 | 0 | 9,557 | |
| Dec 01 2017 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Payment of Exercise | F | 59.49 | 331 | 19,691 | 2,687 | 3 K to 2.7 K (-10.97 %) |
| Dec 01 2017 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Buy | M | 0.00 | 868 | 0 | 3,018 | 2.2 K to 3 K (+40.37 %) |
| Nov 16 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 63.70 | 3,000 | 191,100 | 185,583 | 188.6 K to 185.6 K (-1.59 %) |
| Oct 17 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 84.54 | 3,000 | 253,620 | 188,583 | 191.6 K to 188.6 K (-1.57 %) |
| Sep 18 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 69.50 | 3,000 | 208,500 | 191,583 | 194.6 K to 191.6 K (-1.54 %) |
| Aug 29 2017 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Option Exercise | M | 0.00 | 3,475 | 0 | 10,425 | |
| Aug 29 2017 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Payment of Exercise | F | 73.16 | 1,306 | 95,547 | 2,169 | 3.5 K to 2.2 K (-37.58 %) |
| Aug 29 2017 | CLVS | Clovis Oncology, I ... | Hooks Corwin Dale | See Remarks | Buy | M | 0.00 | 3,475 | 0 | 3,475 | 0 to 3.5 K |
| Aug 29 2017 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Option Exercise | M | 0.00 | 2,188 | 0 | 6,562 | |
| Aug 29 2017 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Payment of Exercise | F | 73.16 | 700 | 51,212 | 2,338 | 3 K to 2.3 K (-23.04 %) |
| Aug 29 2017 | CLVS | Clovis Oncology, I ... | MUEHL DANIEL W | See Remarks | Buy | M | 0.00 | 2,188 | 0 | 3,038 | 850 to 3 K (+257.41 %) |
| Aug 18 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 6,477 | 0 | 9,404 | 2.9 K to 9.4 K (+221.28 %) |
| Aug 18 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Buy | J | 0.00 | 4,835 | 0 | 7,020 | 2.2 K to 7 K (+221.28 %) |
| Aug 18 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | J | 0.00 | 92,518 | 0 | 0 | 92.5 K to 0 (-100.00 %) |
| Aug 15 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 70.05 | 3,000 | 210,150 | 194,583 | 197.6 K to 194.6 K (-1.52 %) |
| Aug 08 2017 | CLVS | Clovis Oncology, I ... | BLAIR JAMES C | Director | Sell | S | 78.61 | 18,450 | 1,450,355 | 17,056 | 35.5 K to 17.1 K (-51.96 %) |
| Jul 17 2017 | CLVS | Clovis Oncology, I ... | IVERS-READ GILLIAN C | See Remarks | Sell | S | 91.56 | 3,000 | 274,680 | 197,583 | 200.6 K to 197.6 K (-1.50 %) |
| Jun 28 2017 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Buy | J | 0.00 | 4,998 | 0 | 25,577 | 20.6 K to 25.6 K (+24.29 %) |
| Jun 28 2017 | CLVS | Clovis Oncology, I ... | ATWOOD BRIAN G | Director | Buy | J | 0.00 | 212 | 0 | 20,579 | 20.4 K to 20.6 K (+1.04 %) |